Detalles de la búsqueda
1.
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Int J Cancer
; 149(11): 1935-1943, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310714
2.
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
Ann Surg Oncol
; 27(7): 2389-2401, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32172334
3.
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study.
Anticancer Drugs
; 31(8): 856-865, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639280
4.
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial.
Int J Cancer
; 145(6): 1538-1546, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30801698
5.
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Int J Cancer
; 142(5): 1047-1055, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29047142
6.
Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
Int J Cancer
; 140(8): 1918-1925, 2017 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28032641
7.
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer.
Anticancer Drugs
; 28(7): 717-722, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28582279
8.
Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3.
Tumour Biol
; 36(4): 2631-40, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472579
9.
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial.
BMC Cancer
; 15: 237, 2015 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25879229
10.
Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment).
Anticancer Drugs
; 25(2): 212-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24201305
11.
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.
Oncol Res Treat
; 46(9): 348-361, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607525
12.
Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study.
AJR Am J Roentgenol
; 198(2): 384-91, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22268182
13.
Toxic epidermal necrolysis after pemetrexed and cisplatin for non-small cell lung cancer in a patient with sharp syndrome.
Onkologie
; 35(12): 783-6, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23207626
14.
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
Cancers (Basel)
; 14(3)2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158793
15.
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Front Oncol
; 12: 751453, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251955
16.
NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literature.
Eur J Cancer
; 153: 86-95, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34153718
17.
Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients.
Cureus
; 12(3): e7305, 2020 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32313746
18.
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
J Cancer Res Clin Oncol
; 146(8): 2077-2087, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32561975
19.
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
Eur J Cancer
; 137: 250-259, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32810748
20.
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study).
Eur J Cancer
; 137: 81-92, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750502